Stanford University
Showing 5,621-5,640 of 7,777 Results
-
Michael Ramsaur
Professor (Teaching) of Theater and Performance Studies, Emeritus
Current Research and Scholarly InterestsEducation for Theatrical Lighting Design, nationally and internationally. Lighting design for Musicals.
-
Meghan Ramsey
Clinical Associate Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
BioDr. Meghan Ramsey is a Clinical Associate Professor in the Division of Pulmonary, Allergy, and Critical Care Medicine. She received her undergraduate degree from Lafayette College in Pennsylvania with a major in Neuroscience. She then attended Stanford University for medical school where she stayed to complete her internal medicine residency, and pulmonary/critical care fellowship. Her clinical time is split between the inpatient setting in the medical ICU and the ambulatory setting in Interventional Pulmonology with a focus on thoracic malignancies. Outside of her clinical time she has a dedicated commitment to teaching, serving as a mentor for residents and fellows, as well as leading as a co-director the pulmonary physiology course for medical students.
-
Mona Ranade
Clinical Associate Professor, Radiology
BioMona Ranade, MD is a radiologist specializing in Vascular & Interventional Radiology and is currently a Clinical Associate Professor of Radiology at Stanford University. She is a board-certified interventional radiologist with a clinical and academic focus on venous thromboembolism (DVT and PE), peripheral arterial disease, superficial venous disease, and women’s interventional health.
She completed her residency in Diagnostic Radiology at the Medical College of Wisconsin (2012–2016) and a fellowship in Vascular & Interventional Radiology at Mount Sinai Hospital in New York (2016–2017). She began her career in academic medicine at the Mount Sinai Health System, where she practiced from 2017 to 2020, followed by five years on faculty at UCLA Health (2020–2025) prior to joining Stanford.
Dr. Ranade is recognized as a thought leader in the treatment of deep vein thrombosis and pulmonary embolism, with extensive experience in managing complex venous disease. She has participated in several clinical trials in this space and currently serves as the national principal investigator for the APEX-AV IDE trial evaluating the AngioDynamics AlphaVac device. Her scholarly work includes multiple peer-reviewed and non–peer-reviewed publications that have advanced clinical understanding and techniques in venous intervention.
In addition to her venous expertise, Dr. Ranade has a strong clinical focus on arterial disease, including the treatment of claudication and critical limb ischemia. She is also highly experienced in the treatment of superficial vein disease, offering comprehensive, minimally invasive options to improve both clinical outcomes and quality of life for her patients.
Dr. Ranade has a deep commitment to improving care for women through minimally invasive therapies, with special research and clinical interests in DVT, PE, and arterial disease in women, as well as uterine fibroids, adenomyosis, and pelvic congestion syndrome. Her work seeks to address the unique presentations and treatment needs of female patients across a range of vascular and interventional conditions.
A proponent of patient-centered innovation, Dr. Ranade has championed procedural advancements such as radial artery access to improve safety, comfort, and recovery. Her approach integrates evidence-based care with a focus on individualized treatment.
Dr. Ranade’s clinical leadership, research contributions, and advocacy for women’s health continue to influence the evolving landscape of interventional radiology. -
Devin Rand-Giovannetti
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Devin Rand-Giovannetti is a licensed psychologist who specializes in the treatment of eating disorders and trauma. She received her BA with Honors from Wellesley College and her doctorate in Clinical Psychology from the University of Hawaiʻi at Mānoa. She completed her clinical internship at the Palo Alto Veterans Affairs Medical Center and her postdoctoral fellowship at Stanford University's School of Medicine. She provides psychotherapy and supervision from a cognitive-behavioral framework. Dr. Rand-Giovannetti currently serves patients through the PTSD and Eating Disorders Clinics at Stanford School of Medicine.
-
Thomas Rando, MD, PhD
Professor of Neurology and Neurological Sciences, Emeritus
Current Research and Scholarly InterestsOur laboratory studies the molecular mechanisms regulating stem cell function, the effects of aging on skeletal muscle and skeletal muscle stem cells, and the pathogenesis and experimental therapeutics for hereditary muscle diseases, specifically the muscular dystrophies.
-
Julia Raney
Clinical Assistant Professor, Pediatrics - Adolescent Medicine
Current Research and Scholarly InterestsAdolescents are dying from drug overdoses at unprecedented rates, largely secondary to fentanyl contamination in the drug supply. A Youth Overdose Prevention Toolkit for school-based health centers is needed to combat this trend. The toolkit should include key stakeholder-informed harm reduction approaches that focus on reducing injury or death from fentanyl and other opioids without exclusively recommending abstinence; this approach is evidence-based and critical to saving lives.
-
Alok Ranjan
Physical Science Research Scientist
BioAccomplished Research Scientist with a rich history (6-8 years) of spearheading cutting-edge research projects. Proficient in synthesizing and analyzing new compounds with therapeutic potential. Experienced in utilizing both structure and property-based strategies to identify promising drug candidates. Led multidisciplinary teams to innovate solutions, enhanced drug discovery efficiency by integrating advanced computational techniques. Committed to continuous learning and staying well-informed of the latest trends in medicinal chemistry and drug design.
-
Julia D. Ransohoff
Instructor, Medicine - Oncology
BioDr. Ransohoff received her B.A. from Harvard College in Human Developmental and Regenerative Biology and completed her medical training at Stanford University, where she received her M.D., completed residency in internal medicine, and fellowship training in hematology and oncology as part of the American Board of Internal Medicine Physician Scientist Training Program.
Dr. Ransohoff is a physician-scientist dedicated to improving breast cancer treatments and outcomes through developing genomic methods to profile how tumors respond to treatment. Her research focuses on molecular approaches to understand the variable clinical responses of breast cancers to treatment at the genomic level by profiling molecular residual disease. Her current work involves exploring mechanisms of chemoresistance and immune evasion and identifying novel therapeutic targets. In related work, she also studies epidemiological risk factors for breast cancer mortality with a focus on the gut microbiome, oncofertility, and racial and ethnic differences in treatment response. Dr. Ransohoff's research has been supported by the ASCO Conquer Cancer Foundation, the Terri Brodeur Breast Cancer Foundation, the Stanford Cancer Institute, ECOG-ACRIN, and the Chan Zuckerberg Initiative.
As an Instructor in the Division of Medical Oncology, Dr. Ransohoff is also a clinically active oncologist, treating patients with breast cancer. -
Anoop Rao
Clinical Associate Professor, Pediatrics - Neonatology
Current Research and Scholarly InterestsWearable senors, unobtrusive vital sign monitoring, natural language processing/text mining
-
Jianghong Rao
Professor of Radiology (Molecular Imaging Program at Stanford) and, by courtesy, of Chemistry
Current Research and Scholarly InterestsProbe chemistry and nanotechnology for molecular imaging and diagnostics
-
Mitesh Rao
Adjunct Clinical Assistant Professor, Emergency Medicine
BioDr. Mitesh B. Rao, MD, MHS is the Founder and CEO of OMNY, a venture-backed company revolutionizing how healthcare data is shared and valued. A Board-Certified Emergency Medicine Physician, Dr. Rao practices clinically as an Assistant Professor of Emergency Medicine at Stanford. Most recently, he served as the Chief Patient Safety Officer for Stanford Healthcare where he led Patient Safety, Quality, and System Redesign for the Enterprise. Dr. Rao also served as Director of the Center for Advancing Patient Safety (CAPS), which focused on advancing the science and implementing new innovations in the fields of Patient Safety and Quality Improvement.
Previously, he was trained in leadership and research skills as a Fellow in the prestigious Robert Wood Johnson Clinical Scholars Program. Subsequent to his time at Yale, he served as the Director of the Patient Safety Education Program at Northwestern Medicine. As a physician leader, he was helped implement systems-level improvements for quality and safety in institutions across the country and overseas that have had lasting effects on patient care provision. He has also led teams serving contracts with various governmental and non-profit agencies such as the Joint Commission Resources, CMS, the Canadian Patient Safety Institute, Partners Health Care, and the American College of Surgeons in multiple campaigns and initiatives to improve Patient Safety on a national level.
Dr. Rao also served as the Head of Research and Integration for the health innovation program at Northwestern. In this role, he developed an expertise in improving care provision through innovative methodologies. He spearheaded efforts to integrate innovative technologies into the health system to improve patient care in a variety of settings, including telemedicine and mHealth initiatives. Working both with innovators and researchers across the various schools of the University as well as promising startups from around the country, Dr. Rao helped guide and refine the process for vetting and integrating pilot programs to test new technologies within the clinical venue. He also serves as a mentor to multiple healthcare-focused startups and accelerator groups across the country in order to help guide the development of implementation of innovative solutions that can sustainably impact patient care provision.
